R William Hipkin Selected Research

Sch 036

1/2007

Cannabinoid CB(2)-selective inverse agonist protects against antigen-induced bone loss.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R William Hipkin Research Topics

Disease

1	Hyperplasia 08/2007
1	Pneumonia (Pneumonitis) 08/2007
1	Experimental Arthritis 04/2007
1	Joint Diseases (Joint Disease) 01/2007
1	Arthritis (Polyarthritis) 01/2007
1	Eosinophilia 02/2006
1	Asthma (Bronchial Asthma) 02/2006
1	Infections 12/2005
1	Multiple Sclerosis 11/2002

Drug/Important Bio-Agent (IBA)

1	Interleukin-8B ReceptorsIBA 08/2007
1	LipopolysaccharidesIBA 08/2007
1	MucinsIBA 08/2007
1	2- hydroxy- N,N- dimethyl- 3- (2- ((1- (5- methylfuran- 2- yl)propyl)amino)- 3,4- dioxocyclobut- 1- enylamino)benzamideIBA 08/2007
1	LigandsIBA 04/2007
1	Sch 036IBA 01/2007
1	CannabinoidsIBA 01/2007
1	OvalbuminIBA 02/2006
1	vicrivirocIBA 12/2005
1	CCR5 Receptors (CCR5 Receptor)IBA 12/2005
1	CC ChemokinesIBA 11/2002

Therapy/Procedure

1	Oral Administration 02/2006
1	Therapeutics 12/2005